Hospital
Community Hospital INC
Community Hospital INC was paid $2.39M by Medicaid between Jan 2018 and Nov 2024, across 46 billing codes. Its largest line is 99284, emergency room visit (serious) — 53% of everything it billed.
33Billing provider infoCOMMUNITY HOSPITAL INC
TALLASSEE, AL 36078
TALLASSEE, AL 36078
33aNPI1730120726assigned 06/09/2006
33bProvider typeRural Acute Care Hospital
28Total paid$2.39M
24GClaims48,074
24DCodes billed46
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Alabama
Rank by total paid#4 of 11
Median peer was paid$1.34M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,278 | $445K | |
| 2019 | 9,151 | $431K | |
| 2020 | 6,940 | $257K | |
| 2021 | 6,682 | $289K | |
| 2022 | 6,236 | $334K | |
| 2023 | 6,119 | $382K | |
| 2024incomplete | 3,668 | $254K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 53% | 20,381 | 13,084 | $1.26M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 32% | 3,414 | 3,071 | $769K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.9% | 5,068 | 4,083 | $190K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 2,152 | 2,076 | $35K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 2,374 | 1,333 | $28K |
| 80053 | Comprehensive metabolic panel | <1% | 1,700 | 1,595 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 376 | 364 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,830 | 1,683 | $15K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,753 | 2,069 | $13K |
| 80061 | Lipid panel | <1% | 587 | 576 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 247 | 236 | $9K |
| 81001 | <1% | 1,951 | 1,819 | $7K |
34 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 404 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 87 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 73 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 225 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 164 | $2K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 48 | $947.95 |
| 99223 | Prolong inpt eval add15 m | <1% | 14 | $796.44 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 77 | $789.69 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 54 | $562.96 |
| 85027 | <1% | 113 | $553.11 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 39 | $529.72 |
| 82248 | <1% | 93 | $450.36 | |
| 82607 | <1% | 24 | $414.48 | |
| 84484 | <1% | 42 | $336.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 191 | $264.60 |
| 74022 | <1% | 12 | $253.70 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $233.48 |
| 84466 | <1% | 16 | $225.84 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,633 | $202.98 |
| 90682 | <1% | 21 | $185.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 94 | $131.78 |
| 83540 | <1% | 16 | $92.76 | |
| 84100 | <1% | 14 | $61.10 | |
| 81025 | <1% | 12 | $33.21 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 170 | $0.01 |
| 1159F | 0% | 17 | $0.00 | |
| 3078F | 0% | 23 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 22 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 148 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 151 | $0.00 |
| 1126F | 0% | 162 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 17 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 19 | $0.00 |
| 3074F | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGREER, LEE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Community Hospital INC | Tallassee, AL | $933K |
| Community Hospital INC | Tuskegee, AL | $710K |
| Community Hospital INC | Tallassee, AL | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.